Principle Wealth Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Principle Wealth Partners’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,550	Closed	-$209K	–	304
2022 Q1	$209K	Sell	4,550 -791	-15%	-$37.7K	0.02%	304
2021 Q4	$327K	Sell	5,341 -5,735	-52%	-$396K	0.03%	245
2021 Q3	$828K	Sell	11,076 -2,488	-18%	-$209K	0.1%	146
2021 Q2	$1.25M	Buy	13,564 +3,286	+32%	+$279K	0.14%	117
2021 Q1	$912K	Buy	10,278 +4,834	+89%	+$479K	0.11%	132
2020 Q4	$508K	Buy	5,444 +1,117	+26%	+$89K	0.07%	175
2020 Q3	$276K	Buy	4,327 +275	+7%	+$16.1K	0.08%	127
2020 Q2	$211K	Buy	+4,052	New	+$174K	0.06%	141
2020 Q1	–	Sell	-6,395	Closed	-$214K	–	141
2019 Q4	$214K	Buy	+6,395	New	+$203K	0.07%	154
2019 Q3	–	Sell	-6,395	Closed	-$220K	–	166
2019 Q2	$220K	Buy	+6,395	New	+$205K	0.11%	127

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Principle Wealth Partners's ARKG Position: Q2 2022 in Review

Principle Wealth Partners sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 4,550 shares — an estimated $209K sold.

Principle Wealth Partners first reported a position in ARKG in Q2 2019 and held it in 10 quarters. The position peaked at $1.25M in Q2 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Principle Wealth Partners reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
Principle Wealth Partners sold 4,550 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $209K.
Principle Wealth Partners first reported a position in ARK Genomic Revolution ETF in Q2 2019 and held it in 10 quarters.
Principle Wealth Partners's ARK Genomic Revolution ETF position peaked at $1.25M in Q2 2021.
333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Principle Wealth Partners's 13F filing for Q2 2022, filed 2 Aug 2022.